TraPR
New gold standard for sRNAs isolation
- Isolate functional, physiologically relevant sRNAs
- Save time with an easy single-column 15-minute protocol
- Extract high-quality sRNA from challenging samples
- Screen for novel sRNAs in uncharacterized samples
- Simplify downstream analysis and save sequencing cost
“We have tested the TraPR columns in our sRNA-Seq workflow on various biofluids and generally observed a good depletion of unwanted RNA fragments, such as rRNA and tRNA. Our main benefit in using TraPR, however, is that it enables us to differentiate between free and RISC-bound miRNAs in the sample types.”
About Lexogen
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.
Email
info@lexogen.com
sales@lexogen.com
Telephone:
US +1-603-431-4300
Rest of the world +43 (0) 1 345 1212
Lexogen ISO certifications
We proudly hold both ISO 9001 and ISO 13485 certifications, which not only demonstrate our drive for innovation but also our unwavering devotion to delivering reliable, robust, and cutting-edge solutions to our valued customers.
